Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Jianhua Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Cont…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit nennt 7 Literaturangaben. Gefördert von: This study was supported by National Natural Science Foundation of China, Grant/Award Number: 82151220 and the Medical and Health Research Project of Zhejiang….
Abstract (Originalsprache)
The recently mutated Omicron variant of SARS‐CoV‐2 exhibits extremely high infectivity and strong evolution and immune escape capabilities. Given the unique epidemic prevention policies of China, we collected 16 sets of sera from convalescent individuals (n = 308) with breakthrough infections who had received different immunization regimens and from healthy people over the subsequent year after epidemic control ceased in China on 7 December 2022. We assessed the susceptibility of the serum to the prototype, Omicron BA.5.2, Omicron XBB.1.5, and Omicron JN.1.5 subvariants at 3‐, 5‐, 8‐ and 11‐months postinfection. The results demonstrated that two booster immunizations did not enhance the immune response, indicating that breakthrough Omicron infection does not effectively increase immunity against other Omicron subvariants. Rather, the breakthrough infection might even weaken the immune response to Omicron subvariants due to antigenic imprinting, highlighting the necessity of optimizing vaccination strategies and adjusting epidemic prevention measures to the situation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, P. R. China.
- Zhejiang Chinese Medical University, Hangzhou, P. R. China.
- Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, P. R. China.
ORCID-Profile: Keda Chen
Förderung
- This study was supported by National Natural Science Foundation of China, Grant/Award Number: 82151220 and the Medical and Health Research Project of Zhejiang…
Zitieren
APA
Li, J., Wang, X., Li, J., Chen, Y., Huang, C., Li, H., Shi, W., Mao, H., Zhang, Y., & Chen, K. (2025). Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections. Journal of Medical Virology. https://doi.org/10.1002/jmv.70681
Vancouver
Li J, Wang X, Li J, Chen Y, Huang C, Li H, et al. Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections. Journal of Medical Virology. 2025. doi:10.1002/jmv.70681
BibTeX
@article{Li2025,
author = {Li, Jianhua and Wang, Xingxing and Li, Jiaxuan and Chen, Yin and Huang, Chen and Li, Hongyu and Shi, Wen and Mao, Haiyan and Zhang, Yanjun and Chen, Keda},
title = {Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70681}
}
EUVIMED